chr1-1043476-G-A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_198576.4(AGRN):​c.1603+19G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00599 in 1,599,186 control chromosomes in the GnomAD database, including 37 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0068 ( 8 hom., cov: 33)
Exomes 𝑓: 0.0059 ( 29 hom. )

Consequence

AGRN
NM_198576.4 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.891

Publications

1 publications found
Variant links:
Genes affected
AGRN (HGNC:329): (agrin) This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
AGRN Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 8
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 1-1043476-G-A is Benign according to our data. Variant chr1-1043476-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 263164.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00679 (1033/152234) while in subpopulation AFR AF = 0.0108 (450/41542). AF 95% confidence interval is 0.01. There are 8 homozygotes in GnomAd4. There are 489 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGRNNM_198576.4 linkc.1603+19G>A intron_variant Intron 8 of 35 ENST00000379370.7 NP_940978.2 O00468-6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGRNENST00000379370.7 linkc.1603+19G>A intron_variant Intron 8 of 35 1 NM_198576.4 ENSP00000368678.2 O00468-6
AGRNENST00000651234.1 linkc.1288+19G>A intron_variant Intron 7 of 37 ENSP00000499046.1 A0A494C1I6
AGRNENST00000652369.2 linkc.1288+19G>A intron_variant Intron 7 of 34 ENSP00000498543.1 A0A494C0G5
AGRNENST00000620552.4 linkc.1189+19G>A intron_variant Intron 8 of 38 5 ENSP00000484607.1 A0A087X208

Frequencies

GnomAD3 genomes
AF:
0.00677
AC:
1030
AN:
152118
Hom.:
8
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0108
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.00412
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00434
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00687
Gnomad OTH
AF:
0.00767
GnomAD2 exomes
AF:
0.00492
AC:
1080
AN:
219586
AF XY:
0.00479
show subpopulations
Gnomad AFR exome
AF:
0.0115
Gnomad AMR exome
AF:
0.00300
Gnomad ASJ exome
AF:
0.000525
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000994
Gnomad NFE exome
AF:
0.00734
Gnomad OTH exome
AF:
0.00501
GnomAD4 exome
AF:
0.00591
AC:
8546
AN:
1446952
Hom.:
29
Cov.:
35
AF XY:
0.00580
AC XY:
4178
AN XY:
720010
show subpopulations
African (AFR)
AF:
0.0109
AC:
364
AN:
33380
American (AMR)
AF:
0.00316
AC:
139
AN:
43944
Ashkenazi Jewish (ASJ)
AF:
0.000809
AC:
21
AN:
25956
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39404
South Asian (SAS)
AF:
0.00299
AC:
256
AN:
85748
European-Finnish (FIN)
AF:
0.00141
AC:
61
AN:
43258
Middle Eastern (MID)
AF:
0.00590
AC:
34
AN:
5762
European-Non Finnish (NFE)
AF:
0.00664
AC:
7364
AN:
1109456
Other (OTH)
AF:
0.00511
AC:
307
AN:
60044
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
566
1131
1697
2262
2828
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
262
524
786
1048
1310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00679
AC:
1033
AN:
152234
Hom.:
8
Cov.:
33
AF XY:
0.00657
AC XY:
489
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.0108
AC:
450
AN:
41542
American (AMR)
AF:
0.00412
AC:
63
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5162
South Asian (SAS)
AF:
0.00434
AC:
21
AN:
4834
European-Finnish (FIN)
AF:
0.000659
AC:
7
AN:
10618
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00687
AC:
467
AN:
67996
Other (OTH)
AF:
0.00759
AC:
16
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
54
109
163
218
272
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00607
Hom.:
1
Bravo
AF:
0.00746
Asia WGS
AF:
0.00289
AC:
10
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 12, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

AGRN: BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Congenital myasthenic syndrome 8 Benign:2
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 26, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
12
DANN
Benign
0.62
PhyloP100
-0.89
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.25
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.25
Position offset: -8

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115191992; hg19: chr1-978856; COSMIC: COSV65070034; COSMIC: COSV65070034; API